GF
SCMP

Gerstein Fisher’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Gerstein Fisher’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-43,756
Closed -$478K – 443
2016
Q1 		$478K Buy
43,756
+16,736
+62% +$211K 0.07% 233
2015
Q4 		$467K Sell
27,020
-127
-0.5% -$2.28K 0.07% 236
2015
Q3 		$539K Hold
27,147
– – 0.08% 216
2015
Q2 		$446K Buy
27,147
+127
+0.5% +$2.2K 0.07% 257
2015
Q1 		$420K Buy
+27,020
New +$419K 0.07% 259

Other funds holding SCMP

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Gerstein Fisher's SCMP Position: Q2 2016 in Review

Gerstein Fisher sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2016, closing a stake of 43,756 shares — an estimated $478K sold.

Gerstein Fisher first reported a position in SCMP in Q1 2015 and held it in 5 quarters. The position peaked at $539K in Q3 2015. 136 funds tracked by Wall St. Rank hold SCMP as of Q2 2016.

  • Gerstein Fisher reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Gerstein Fisher sold 43,756 Sucampo Pharmaceuticals, Inc. shares in Q2 2016, an estimated $478K.
  • Gerstein Fisher first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
  • Gerstein Fisher's Sucampo Pharmaceuticals, Inc. position peaked at $539K in Q3 2015.
  • 136 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2016.

Based on Gerstein Fisher's 13F filing for Q2 2016, filed 8 Aug 2016.